Mouse Fam221b Knockout Project (CRISPR/Cas9)

Total Page:16

File Type:pdf, Size:1020Kb

Mouse Fam221b Knockout Project (CRISPR/Cas9) https://www.alphaknockout.com Mouse Fam221b Knockout Project (CRISPR/Cas9) Objective: To create a Fam221b knockout Mouse model (C57BL/6J) by CRISPR/Cas-mediated genome engineering. Strategy summary: The Fam221b gene (NCBI Reference Sequence: NM_175517 ; Ensembl: ENSMUSG00000043633 ) is located on Mouse chromosome 4. 7 exons are identified, with the ATG start codon in exon 2 and the TGA stop codon in exon 7 (Transcript: ENSMUST00000056474). Exon 2~7 will be selected as target site. Cas9 and gRNA will be co-injected into fertilized eggs for KO Mouse production. The pups will be genotyped by PCR followed by sequencing analysis. Note: Male mice homozygous for a null allele exhibit normal fecundity. Exon 2 starts from about 0.07% of the coding region. Exon 2~7 covers 100.0% of the coding region. The size of effective KO region: ~6950 bp. The KO region does not have any other known gene. Page 1 of 9 https://www.alphaknockout.com Overview of the Targeting Strategy Wildtype allele 5' gRNA region gRNA region 3' 1 2 3 4 5 6 7 Legends Exon of mouse Fam221b Knockout region Page 2 of 9 https://www.alphaknockout.com Overview of the Dot Plot (up) Window size: 15 bp Forward Reverse Complement Sequence 12 Note: The 2000 bp section upstream of start codon is aligned with itself to determine if there are tandem repeats. No significant tandem repeat is found in the dot plot matrix. So this region is suitable for PCR screening or sequencing analysis. Overview of the Dot Plot (down) Window size: 15 bp Forward Reverse Complement Sequence 12 Note: The 2000 bp section downstream of stop codon is aligned with itself to determine if there are tandem repeats. No significant tandem repeat is found in the dot plot matrix. So this region is suitable for PCR screening or sequencing analysis. Page 3 of 9 https://www.alphaknockout.com Overview of the GC Content Distribution (up) Window size: 300 bp Sequence 12 Summary: Full Length(2000bp) | A(25.6% 512) | C(23.05% 461) | T(26.2% 524) | G(25.15% 503) Note: The 2000 bp section upstream of start codon is analyzed to determine the GC content. No significant high GC-content region is found. So this region is suitable for PCR screening or sequencing analysis. Overview of the GC Content Distribution (down) Window size: 300 bp Sequence 12 Summary: Full Length(2000bp) | A(30.05% 601) | C(18.95% 379) | T(22.65% 453) | G(28.35% 567) Note: The 2000 bp section downstream of stop codon is analyzed to determine the GC content. No significant high GC-content region is found. So this region is suitable for PCR screening or sequencing analysis. Page 4 of 9 https://www.alphaknockout.com BLAT Search Results (up) QUERY SCORE START END QSIZE IDENTITY CHROM STRAND START END SPAN ----------------------------------------------------------------------------------------------- browser details YourSeq 2000 1 2000 2000 100.0% chr4 - 43666610 43668609 2000 browser details YourSeq 61 206 373 2000 91.9% chr9 - 67528536 67528710 175 browser details YourSeq 51 577 668 2000 78.6% chr1 - 64637249 64637316 68 browser details YourSeq 51 196 255 2000 94.7% chrX + 160171731 160172267 537 browser details YourSeq 51 583 668 2000 96.4% chr7 + 126805804 126805898 95 browser details YourSeq 51 198 378 2000 77.8% chr17 + 27418922 27419089 168 browser details YourSeq 50 207 378 2000 86.2% chr10 - 85900377 85900547 171 browser details YourSeq 49 222 378 2000 91.4% chr2 - 172285266 172285424 159 browser details YourSeq 46 218 379 2000 92.6% chr3 - 94990872 94991044 173 browser details YourSeq 46 577 668 2000 94.3% chr1 + 157863738 157863831 94 browser details YourSeq 45 221 373 2000 91.7% chr9 - 86830595 86830746 152 browser details YourSeq 45 575 668 2000 85.8% chr11 + 96159866 96160082 217 browser details YourSeq 45 199 303 2000 78.9% chr10 + 41938261 41938356 96 browser details YourSeq 44 221 361 2000 94.0% chr6 - 86097001 86097147 147 browser details YourSeq 44 221 332 2000 94.0% chr12 - 116459255 116459366 112 browser details YourSeq 44 199 295 2000 81.3% chr7 + 16441517 16441602 86 browser details YourSeq 44 221 312 2000 94.0% chr6 + 113005276 113005368 93 browser details YourSeq 44 220 295 2000 92.2% chr2 + 163506154 163506231 78 browser details YourSeq 43 216 261 2000 97.8% chrX - 101121509 101121558 50 browser details YourSeq 43 628 983 2000 62.5% chr11 + 59116834 59116995 162 Note: The 2000 bp section upstream of start codon is BLAT searched against the genome. No significant similarity is found. BLAT Search Results (down) QUERY SCORE START END QSIZE IDENTITY CHROM STRAND START END SPAN ----------------------------------------------------------------------------------------------- browser details YourSeq 2000 1 2000 2000 100.0% chr4 - 43657658 43659657 2000 browser details YourSeq 37 1953 2000 2000 95.2% chr5 - 151201272 151201348 77 browser details YourSeq 34 1950 1992 2000 90.5% chr9 - 97080811 97080883 73 browser details YourSeq 34 1953 1992 2000 92.5% chr2 - 26084346 26084385 40 browser details YourSeq 34 1951 1996 2000 87.0% chr17 + 31661791 31661836 46 browser details YourSeq 32 1949 2000 2000 80.8% chr6 - 25569991 25570042 52 browser details YourSeq 32 1949 2000 2000 80.8% chr18 - 52438461 52438512 52 browser details YourSeq 32 1951 2000 2000 82.0% chr12 - 108343616 108343665 50 browser details YourSeq 32 1953 1996 2000 86.4% chr12 - 70706351 70706394 44 browser details YourSeq 32 1951 2000 2000 82.0% chr1 - 120711702 120711751 50 browser details YourSeq 32 1954 1992 2000 97.1% chr11 + 87332460 87332527 68 browser details YourSeq 31 1958 2000 2000 86.1% chr11 + 107345204 107345246 43 browser details YourSeq 30 1953 2000 2000 81.3% chr6 - 85316012 85316059 48 browser details YourSeq 30 1951 1983 2000 96.9% chr4 - 141108965 141109025 61 browser details YourSeq 30 1953 2000 2000 81.3% chr6 + 42901334 42901381 48 browser details YourSeq 30 1949 2000 2000 78.9% chr5 + 17118020 17118071 52 browser details YourSeq 30 1953 2000 2000 81.3% chr15 + 79608979 79609026 48 browser details YourSeq 30 1949 1992 2000 91.7% chr15 + 65841495 65841540 46 browser details YourSeq 29 1949 1979 2000 96.8% chr2 - 20952239 20952269 31 browser details YourSeq 29 1950 1979 2000 100.0% chr15 - 92807256 92807287 32 Note: The 2000 bp section downstream of stop codon is BLAT searched against the genome. No significant similarity is found. Page 5 of 9 https://www.alphaknockout.com Gene and protein information: Fam221b family with sequence similarity 221, member B [ Mus musculus (house mouse) ] Gene ID: 242408, updated on 8-Oct-2019 Gene summary Official Symbol Fam221b provided by MGI Official Full Name family with sequence similarity 221, member B provided by MGI Primary source MGI:MGI:2441678 See related Ensembl:ENSMUSG00000043633 Gene type protein coding RefSeq status PREDICTED Organism Mus musculus Lineage Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae; Murinae; Mus; Mus Also known as 4930412F15Rik Expression Restricted expression toward testis adult (RPKM 93.3) See more Orthologs human all Genomic context Location: 4; 4 A5 See Fam221b in Genome Data Viewer Exon count: 7 Annotation release Status Assembly Chr Location 108 current GRCm38.p6 (GCF_000001635.26) 4 NC_000070.6 (43659622..43668859, complement) Build 37.2 previous assembly MGSCv37 (GCF_000001635.18) 4 NC_000070.5 (43672494..43681731, complement) Chromosome 4 - NC_000070.6 Page 6 of 9 https://www.alphaknockout.com Transcript information: This gene has 2 transcripts Gene: Fam221b ENSMUSG00000043633 Description family with sequence similarity 221, member B [Source:MGI Symbol;Acc:MGI:2441678] Gene Synonyms 4930412F15Rik Location Chromosome 4: 43,659,622-43,669,145 reverse strand. GRCm38:CM000997.2 About this gene This gene has 2 transcripts (splice variants), 86 orthologues, 1 paralogue and is a member of 1 Ensembl protein family. Transcripts Name Transcript ID bp Protein Translation ID Biotype CCDS UniProt Flags Fam221b-201 ENSMUST00000056474.6 2045 487aa ENSMUSP00000057398.6 Protein coding CCDS18107 Q8C627 TSL:1 GENCODE basic APPRIS P1 Fam221b-202 ENSMUST00000134487.1 3913 No protein - Retained intron - - TSL:1 Page 7 of 9 https://www.alphaknockout.com 29.52 kb Forward strand 43.65Mb 43.66Mb 43.67Mb Genes Npr2-201 >protein coding Gm12481-201 >processed pseudoTgmeenme 8b-204 >lncRNA (Comprehensive set... Npr2-202 >protein coding Tmem8b-202 >protein coding Npr2-204 >lncRNA Tmem8b-209 >protein coding Npr2-205 >protein coding Tmem8b-201 >protein coding Npr2-206 >lncRNA Tmem8b-203 >protein coding Npr2-210 >lncRNA Tmem8b-206 >protein coding Tmem8b-207 >lncRNA Tmem8b-205 >lncRNA Contigs AL732626.8 > Genes (Comprehensive set... < Spag8-201protein coding < Fam221b-201protein coding < Spag8-203protein coding < Fam221b-202retained intron < Spag8-202protein coding < Hint2-202lncRNA < Hint2-205lncRNA < Hint2-203lncRNA < Hint2-201protein coding < Hint2-204lncRNA < Hint2-206lncRNA < Hint2-207lncRNA Regulatory Build 43.65Mb 43.66Mb 43.67Mb Reverse strand 29.52 kb Regulation Legend CTCF Enhancer Open Chromatin Promoter Promoter Flank Transcription Factor Binding Site Gene Legend Protein Coding merged Ensembl/Havana Ensembl protein coding Non-Protein Coding pseudogene RNA gene processed transcript Page 8 of 9 https://www.alphaknockout.com Transcript: ENSMUST00000056474 < Fam221b-201protein coding Reverse strand 9.52 kb ENSMUSP00000057... MobiDB lite Low complexity (Seg) Pfam Protein FAM221A/B PANTHER Protein FAM221A/B PTHR31214:SF3 All sequence SNPs/i... Sequence variants (dbSNP and all other sources) Variant Legend inframe deletion missense variant synonymous variant Scale bar 0 60 120 180 240 300 360 420 487 We wish to acknowledge the following valuable scientific information resources: Ensembl, MGI, NCBI, UCSC. Page 9 of 9.
Recommended publications
  • Genome-Wide Association Study of Behavioral Disinhibition in a Selected Adolescent Sample Jaime Derringer *, Robin P. Corley
    Genome-wide association study of behavioral disinhibition in a selected adolescent sample Jaime Derringer1*, Robin P. Corley2, Brett C. Haberstick2, Susan E. Young2, Brittany Demmitt2, Daniel P. Howrigan3, Robert M. Kirkpatrick4, William G. Iacono5, Matt McGue5, Matthew Keller2, Sandra Brown6, Susan Tapert6, Christian J. Hopfer7, Michael C. Stallings2, Thomas J. Crowley7, Soo Hyun Rhee2, Ken Krauter2, John K. Hewitt2, Matthew B. McQueen2 1 University of Illinois Urbana-Champaign, 2 University of Colorado Boulder, 3 Massachusetts General Hospital/Harvard Medical School, 4 Virginia Commonwealth University, 5 University of Minnesota, 6 University of California San Diego, 7 University of Colorado Denver * Corresponding Author: Jaime Derringer, [email protected], Department of Psychology, University of Illinois Urbana-Champaign, Champaign IL USA 61820 Behavioral disinhibition GWAS 2 Abstract Behavioral disinhibition (BD) is a quantitative measure designed to capture the heritable variation encompassing risky and impulsive behaviors. As a result, BD represents an ideal target for discovering genetic loci that predispose individuals to a wide range of antisocial behaviors and substance misuse that together represent a large cost to society as a whole. Published genome-wide association studies (GWAS) have examined specific phenotypes that fall under the umbrella of BD (e.g. alcohol dependence, conduct disorder); however no GWAS has specifically examined the overall BD construct. We conducted a GWAS of BD using a sample of 1,901 adolescents over-selected for characteristics that define high BD, such as substance and antisocial behavior problems, finding no individual locus that surpassed genome-wide significance. Although no single SNP was significantly associated with BD, restricted maximum likelihood analysis estimated that 49.3% of the variance in BD within the Caucasian sub-sample was accounted for by the genotyped SNPs (p=0.06).
    [Show full text]
  • Sanjay Kumar Gupta
    The human CCHC-type Zinc Finger Nucleic Acid Binding Protein (CNBP) binds to the G-rich elements in target mRNA coding sequences and promotes translation Das humane CCHC-Typ-Zinkfinger-Nukleinsäure-Binde-Protein (CNBP) bindet an G-reiche Elemente in der kodierenden Sequenz seiner Ziel-mRNAs und fördert deren Translation Doctoral thesis for a doctoral degree at the Graduate School of Life Sciences, Julius-Maximilians-Universität WürzBurg, Section: Biomedicine suBmitted By Sanjay Kumar Gupta from Varanasi, India WürzBurg, 2016 1 Submitted on: …………………………………………………………..…….. Office stamp Members of the Promotionskomitee: Chairperson: Prof. Dr. Alexander Buchberger Primary Supervisor: Dr. Stefan Juranek Supervisor (Second): Prof. Dr. Utz Fischer Supervisor (Third): Dr. Markus Landthaler Date of Public Defence: …………………………………………….………… Date of Receipt of Certificates: ………………………………………………. 2 Summary The genetic information encoded with in the genes are transcribed and translated to give rise to the functional proteins, which are building block of a cell. At first, it was thought that the regulation of gene expression particularly occurs at the level of transcription By various transcription factors. Recent discoveries have shown the vital role of gene regulation at the level of RNA also known as post-transcriptional gene regulation (PTGR). Apart from non-coding RNAs e.g. micro RNAs, various RNA Binding proteins (RBPs) play essential role in PTGR. RBPs have been implicated in different stages of mRNA life cycle ranging from splicing, processing, transport, localization and decay. In last 20 years studies have shown the presence of hundreds of RBPs across eukaryotic systems many of which are widely conserved. Given the rising numBer of RBPs and their link to human diseases it is quite evident that RBPs have major role in cellular processes and their regulation.
    [Show full text]
  • PDF Output of CLIC (Clustering by Inferred Co-Expression)
    PDF Output of CLIC (clustering by inferred co-expression) Dataset: Num of genes in input gene set: 7 Total number of genes: 16493 CLIC PDF output has three sections: 1) Overview of Co-Expression Modules (CEMs) Heatmap shows pairwise correlations between all genes in the input query gene set. Red lines shows the partition of input genes into CEMs, ordered by CEM strength. Each row shows one gene, and the brightness of squares indicates its correlations with other genes. Gene symbols are shown at left side and on the top of the heatmap. 2) Details of each CEM and its expansion CEM+ Top panel shows the posterior selection probability (dataset weights) for top GEO series datasets. Bottom panel shows the CEM genes (blue rows) as well as expanded CEM+ genes (green rows). Each column is one GEO series dataset, sorted by their posterior probability of being selected. The brightness of squares indicates the gene's correlations with CEM genes in the corresponding dataset. CEM+ includes genes that co-express with CEM genes in high-weight datasets, measured by LLR score. 3) Details of each GEO series dataset and its expression profile: Top panel shows the detailed information (e.g. title, summary) for the GEO series dataset. Bottom panel shows the background distribution and the expression profile for CEM genes in this dataset. Overview of Co-Expression Modules (CEMs) with Dataset Weighting Scale of average Pearson correlations Num of Genes in Query Geneset: 7. Num of CEMs: 1. 0.0 0.2 0.4 0.6 0.8 1.0 Ctr9 Rtf1 Paf1 Cdc73 Leo1 Wdr61 Pex2 Ctr9 Rtf1
    [Show full text]
  • Protein Identities in Evs Isolated from U87-MG GBM Cells As Determined by NG LC-MS/MS
    Protein identities in EVs isolated from U87-MG GBM cells as determined by NG LC-MS/MS. No. Accession Description Σ Coverage Σ# Proteins Σ# Unique Peptides Σ# Peptides Σ# PSMs # AAs MW [kDa] calc. pI 1 A8MS94 Putative golgin subfamily A member 2-like protein 5 OS=Homo sapiens PE=5 SV=2 - [GG2L5_HUMAN] 100 1 1 7 88 110 12,03704523 5,681152344 2 P60660 Myosin light polypeptide 6 OS=Homo sapiens GN=MYL6 PE=1 SV=2 - [MYL6_HUMAN] 100 3 5 17 173 151 16,91913397 4,652832031 3 Q6ZYL4 General transcription factor IIH subunit 5 OS=Homo sapiens GN=GTF2H5 PE=1 SV=1 - [TF2H5_HUMAN] 98,59 1 1 4 13 71 8,048185945 4,652832031 4 P60709 Actin, cytoplasmic 1 OS=Homo sapiens GN=ACTB PE=1 SV=1 - [ACTB_HUMAN] 97,6 5 5 35 917 375 41,70973209 5,478027344 5 P13489 Ribonuclease inhibitor OS=Homo sapiens GN=RNH1 PE=1 SV=2 - [RINI_HUMAN] 96,75 1 12 37 173 461 49,94108966 4,817871094 6 P09382 Galectin-1 OS=Homo sapiens GN=LGALS1 PE=1 SV=2 - [LEG1_HUMAN] 96,3 1 7 14 283 135 14,70620005 5,503417969 7 P60174 Triosephosphate isomerase OS=Homo sapiens GN=TPI1 PE=1 SV=3 - [TPIS_HUMAN] 95,1 3 16 25 375 286 30,77169764 5,922363281 8 P04406 Glyceraldehyde-3-phosphate dehydrogenase OS=Homo sapiens GN=GAPDH PE=1 SV=3 - [G3P_HUMAN] 94,63 2 13 31 509 335 36,03039959 8,455566406 9 Q15185 Prostaglandin E synthase 3 OS=Homo sapiens GN=PTGES3 PE=1 SV=1 - [TEBP_HUMAN] 93,13 1 5 12 74 160 18,68541938 4,538574219 10 P09417 Dihydropteridine reductase OS=Homo sapiens GN=QDPR PE=1 SV=2 - [DHPR_HUMAN] 93,03 1 1 17 69 244 25,77302971 7,371582031 11 P01911 HLA class II histocompatibility antigen,
    [Show full text]
  • Molecular Characterization of Acute Myeloid Leukemia by Next Generation Sequencing: Identification of Novel Biomarkers and Targets of Personalized Therapies
    Alma Mater Studiorum – Università di Bologna Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale Dottorato di Ricerca in Oncologia, Ematologia e Patologia XXX Ciclo Settore Scientifico Disciplinare: MED/15 Settore Concorsuale:06/D3 Molecular characterization of acute myeloid leukemia by Next Generation Sequencing: identification of novel biomarkers and targets of personalized therapies Presentata da: Antonella Padella Coordinatore Prof. Pier-Luigi Lollini Supervisore: Prof. Giovanni Martinelli Esame finale anno 2018 Abstract Acute myeloid leukemia (AML) is a hematopoietic neoplasm that affects myeloid progenitor cells and it is one of the malignancies best studied by next generation sequencing (NGS), showing a highly heterogeneous genetic background. The aim of the study was to characterize the molecular landscape of 2 subgroups of AML patients carrying either chromosomal number alterations (i.e. aneuploidy) or rare fusion genes. We performed whole exome sequencing and we integrated the mutational data with transcriptomic and copy number analysis. We identified the cell cycle, the protein degradation, response to reactive oxygen species, energy metabolism and biosynthetic process as the pathways mostly targeted by alterations in aneuploid AML. Moreover, we identified a 3-gene expression signature including RAD50, PLK1 and CDC20 that characterize this subgroup. Taking advantage of RNA sequencing we aimed at the discovery of novel and rare gene fusions. We detected 9 rare chimeric transcripts, of which partner genes were transcription factors (ZEB2, BCL11B and MAFK) or tumor suppressors (SAV1 and PUF60) rarely translocated across cancer types. Moreover, we detected cryptic events hiding the loss of NF1 and WT1, two recurrently altered genes in AML. Finally, we explored the oncogenic potential of the ZEB2-BCL11B fusion, which revealed no transforming ability in vitro.
    [Show full text]
  • Genome-Wide Determination of On-Target and Off-Target Characteristics for RNA-Guided DNA Methylation by Dcas9 Methyltransferases.” Gigascience 7 (3): Giy011
    Genome-wide determination of on- target and off-target characteristics for RNA-guided DNA methylation by dCas9 methyltransferases The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters Citation Lin, L., Y. Liu, F. Xu, J. Huang, T. F. Daugaard, T. S. Petersen, B. Hansen, et al. 2018. “Genome-wide determination of on-target and off-target characteristics for RNA-guided DNA methylation by dCas9 methyltransferases.” GigaScience 7 (3): giy011. doi:10.1093/ gigascience/giy011. http://dx.doi.org/10.1093/gigascience/giy011. Published Version doi:10.1093/gigascience/giy011 Citable link http://nrs.harvard.edu/urn-3:HUL.InstRepos:37068160 Terms of Use This article was downloaded from Harvard University’s DASH repository, and is made available under the terms and conditions applicable to Other Posted Material, as set forth at http:// nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of- use#LAA GigaScience, 7, 2018, 1–19 doi: 10.1093/gigascience/giy011 Advance Access Publication Date: 19 February 2018 Research RESEARCH Genome-wide determination of on-target and off-target characteristics for RNA-guided DNA methylation by dCas9 methyltransferases Lin Lin1,2,†,YongLiu1,†, Fengping Xu3,4,5,†,JinrongHuang3,4,5,†, Tina Fuglsang Daugaard1, Trine Skov Petersen1, Bettina Hansen1, Lingfei Ye3,QingZhou3,4, Fang Fang3,4,LingYang3,4, Shengting Li1,3, Lasse Fløe1, Kristopher Torp Jensen1, Ellen Shrock6, Fang Chen3,4,5, Huanming Yang3,4,7,JianWang3,4,XinLiu3,4,XunXu3,4,∗, Lars Bolund1,3,4,2,8,9, Anders Lade Nielsen1 and Yonglun Luo1,3,4,2,8,9,10,∗ 1Department of Biomedicine, Aarhus University, Aarhus, Denmark, 2Danish Regenerative Engineering Alliance for Medicine, Department of Biomedicine, Aarhus University, Aarhus, Denmark, 3BGI-Shenzhen, Shenzhen 518083, China, 4China National GeneBank-Shenzhen, BGI-Research, Shenzhen 518083, China, 5Department of Biology, University of Copenhagen, Copenhagen, Denmark, 6Department of Genetics, Harvard Medical School, Boston, MA, USA, 7James D.
    [Show full text]
  • Misexpression of Cancer/Testis (Ct) Genes in Tumor Cells and the Potential Role of Dream Complex and the Retinoblastoma Protein Rb in Soma-To-Germline Transformation
    Michigan Technological University Digital Commons @ Michigan Tech Dissertations, Master's Theses and Master's Reports 2019 MISEXPRESSION OF CANCER/TESTIS (CT) GENES IN TUMOR CELLS AND THE POTENTIAL ROLE OF DREAM COMPLEX AND THE RETINOBLASTOMA PROTEIN RB IN SOMA-TO-GERMLINE TRANSFORMATION SABHA M. ALHEWAT Michigan Technological University, [email protected] Copyright 2019 SABHA M. ALHEWAT Recommended Citation ALHEWAT, SABHA M., "MISEXPRESSION OF CANCER/TESTIS (CT) GENES IN TUMOR CELLS AND THE POTENTIAL ROLE OF DREAM COMPLEX AND THE RETINOBLASTOMA PROTEIN RB IN SOMA-TO- GERMLINE TRANSFORMATION", Open Access Master's Thesis, Michigan Technological University, 2019. https://doi.org/10.37099/mtu.dc.etdr/933 Follow this and additional works at: https://digitalcommons.mtu.edu/etdr Part of the Cancer Biology Commons, and the Cell Biology Commons MISEXPRESSION OF CANCER/TESTIS (CT) GENES IN TUMOR CELLS AND THE POTENTIAL ROLE OF DREAM COMPLEX AND THE RETINOBLASTOMA PROTEIN RB IN SOMA-TO-GERMLINE TRANSFORMATION By Sabha Salem Alhewati A THESIS Submitted in partial fulfillment of the requirements for the degree of MASTER OF SCIENCE In Biological Sciences MICHIGAN TECHNOLOGICAL UNIVERSITY 2019 © 2019 Sabha Alhewati This thesis has been approved in partial fulfillment of the requirements for the Degree of MASTER OF SCIENCE in Biological Sciences. Department of Biological Sciences Thesis Advisor: Paul Goetsch. Committee Member: Ebenezer Tumban. Committee Member: Zhiying Shan. Department Chair: Chandrashekhar Joshi. Table of Contents List of figures .......................................................................................................................v
    [Show full text]
  • Supplementary File 1
    Supplementary Materials Figure S1. RNA sequencing quality control report. The upper panel showed per base sequence quality of (a) miRNA from 786-O and ACHN, and (b) RNA from 786-O and ACHN; the lower panel showed the per sequence quality scores of (c) miRNA from 786-O and ACHN, and (d) RNA from 786-O and ACHN. The quality score from 15 to 99 bp fell into the green background, indicating good quality calls. The majority read > 35 indicated good sequencing quality. Table S1. The list of miRNA with significant changes (ACHN vs 786-O) #miRNA Fold Change #miRNA Fold Change #miRNA Fold Change hsa-let-7a-2-3p -490.00 hsa-miR-192-5p 21.37 hsa-miR-323a-3p 135.76 hsa-let-7c-3p -10.30 hsa-miR-194-3p 31.18 hsa-miR-323b-3p 53.75 hsa-miR-100-3p -26.39 hsa-miR-194-5p 21.87 hsa-miR-326 -16.46 hsa-miR-100-5p -63.93 hsa-miR-195-5p 8.31 hsa-miR-329-3p 101.81 hsa-miR-105-5p -288.00 hsa-miR-196a-3p 5.28 hsa-miR-329-5p 436 hsa-miR-1185-1-3p 32.08 hsa-miR-199b-5p -9.75 hsa-miR-335-3p 73.67 hsa-miR-1185-2-3p 37.22 hsa-miR-203a-3p 222.25 hsa-miR-335-5p 71.58 hsa-miR-1185-5p 91.13 hsa-miR-205-5p -5.12 hsa-miR-337-3p 1696 hsa-miR-1197 7.38 hsa-miR-20b-5p 5.28 hsa-miR-337-5p 12141 hsa-miR-125b-1-3p -301.58 hsa-miR-211-5p 118 hsa-miR-34b-3p 1110.62 hsa-miR-125b-2-3p 5.91 hsa-miR-215-5p 18.88 hsa-miR-34b-5p 796.38 hsa-miR-1262 16.28 hsa-miR-218-5p 14.37 hsa-miR-34c-3p 10751 hsa-miR-1266-5p 6.62 hsa-miR-224-5p 118 hsa-miR-34c-5p 836.81 hsa-miR-127-3p 1723.39 hsa-miR-2277-3p 6.65 hsa-miR-3614-5p 141 hsa-miR-127-5p 4334.00 hsa-miR-2682-3p 6.63 hsa-miR-3617-5p -140 hsa-miR-1271-5p
    [Show full text]
  • Novel Gene Discovery in Primary Ciliary Dyskinesia
    Novel Gene Discovery in Primary Ciliary Dyskinesia Mahmoud Raafat Fassad Genetics and Genomic Medicine Programme Great Ormond Street Institute of Child Health University College London A thesis submitted in conformity with the requirements for the degree of Doctor of Philosophy University College London 1 Declaration I, Mahmoud Raafat Fassad, confirm that the work presented in this thesis is my own. Where information has been derived from other sources, I confirm that this has been indicated in the thesis. 2 Abstract Primary Ciliary Dyskinesia (PCD) is one of the ‘ciliopathies’, genetic disorders affecting either cilia structure or function. PCD is a rare recessive disease caused by defective motile cilia. Affected individuals manifest with neonatal respiratory distress, chronic wet cough, upper respiratory tract problems, progressive lung disease resulting in bronchiectasis, laterality problems including heart defects and adult infertility. Early diagnosis and management are essential for better respiratory disease prognosis. PCD is a highly genetically heterogeneous disorder with causal mutations identified in 36 genes that account for the disease in about 70% of PCD cases, suggesting that additional genes remain to be discovered. Targeted next generation sequencing was used for genetic screening of a cohort of patients with confirmed or suggestive PCD diagnosis. The use of multi-gene panel sequencing yielded a high diagnostic output (> 70%) with mutations identified in known PCD genes. Over half of these mutations were novel alleles, expanding the mutation spectrum in PCD genes. The inclusion of patients from various ethnic backgrounds revealed a striking impact of ethnicity on the composition of disease alleles uncovering a significant genetic stratification of PCD in different populations.
    [Show full text]
  • RNA Splicing in the Transition from B Cells
    RNA Splicing in the Transition from B Cells to Antibody-Secreting Cells: The Influences of ELL2, Small Nuclear RNA, and Endoplasmic Reticulum Stress This information is current as of September 24, 2021. Ashley M. Nelson, Nolan T. Carew, Sage M. Smith and Christine Milcarek J Immunol 2018; 201:3073-3083; Prepublished online 8 October 2018; doi: 10.4049/jimmunol.1800557 Downloaded from http://www.jimmunol.org/content/201/10/3073 Supplementary http://www.jimmunol.org/content/suppl/2018/10/05/jimmunol.180055 http://www.jimmunol.org/ Material 7.DCSupplemental References This article cites 44 articles, 16 of which you can access for free at: http://www.jimmunol.org/content/201/10/3073.full#ref-list-1 Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision by guest on September 24, 2021 • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2018 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology RNA Splicing in the Transition from B Cells to Antibody-Secreting Cells: The Influences of ELL2, Small Nuclear RNA, and Endoplasmic Reticulum Stress Ashley M.
    [Show full text]
  • Combinatorial Strategies Using CRISPR/Cas9 for Gene Mutagenesis in Adult Mice
    Combinatorial strategies using CRISPR/Cas9 for gene mutagenesis in adult mice Avery C. Hunker A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy University of Washington 2019 Reading Committee: Larry S. Zweifel, Chair Sheri J. Mizumori G. Stanley McKnight Program Authorized to Offer Degree: Pharmacology 2 © Copyright 2019 Avery C. Hunker 3 University of Washington ABSTRACT Combinatorial strategies using CRISPR/Cas9 for gene mutagenesis in adult mice Avery C. Hunker Chair of the Supervisory Committee: Larry Zweifel Department of Pharmacology A major challenge to understanding how genes modulate complex behaviors is the inability to restrict genetic manipulations to defined cell populations or circuits. To circumvent this, we created a simple strategy for limiting gene knockout to specific cell populations using a viral-mediated, conditional CRISPR/SaCas9 system in combination with intersectional genetic strategies. A small single guide RNA (sgRNA) directs Staphylococcus aureus CRISPR-associated protein (SaCas9) to unique sites on DNA in a Cre-dependent manner resulting in double strand breaks and gene mutagenesis in vivo. To validate this technique we targeted nine different genes of diverse function in distinct cell types in mice and performed an array of analyses to confirm gene mutagenesis and subsequent protein loss, including IHC, cell-type specific DNA sequencing, electrophysiology, Western blots, and behavior. We show that these vectors are as efficient as conventional conditional gene knockout and provide a viable alternative to complex genetic crosses. This strategy provides additional benefits of 4 targeting gene mutagenesis to cell types previously difficult to isolate, and the ability to target genes in specific neural projections for gene inactivation.
    [Show full text]
  • A Thesis Entitled Beta-Defensin 3-Mediated Regulation Of
    A Thesis entitled Beta-Defensin 3-Mediated Regulation of Transcriptional Changes During Oropharyngeal Candidiasis by Cole Jacob White Submitted to the Graduate Faculty as partial fulfillment of the requirements for the Master of Science Degree in Biomedical Science: Bioinformatics, Proteomics and Genomics Dr. Heather Conti, Committee Chair Dr. Alexei Fedorov, Committee Member Dr. Sadik Khuder, Committee Member Dr. Amanda Bryant-Friedrich, Dean College of Graduate Studies The University of Toledo August 2018 Copyright 2018, Cole Jacob White This document is copyrighted material. Under copyright law, no parts of this document may be reproduced without the expressed permission of the author. An Abstract of Beta-Defensin 3-Mediated Regulation of Transcriptional Changes During Oropharyngeal Candidiasis by Cole Jacob White Submitted to the Graduate Faculty as partial fulfillment of the requirements for the Master of Science Degree in Biomedical Science: Bioinformatics, Proteomics and Genomics The University of Toledo August 2018 Oropharyngeal candidiasis (OPC) is a fungal infection of the oral cavity caused by a human commensal fungus called Candida albicans. Even though C. albicans is a commensal, it can become pathogenic in immunocompromised patients. IL-17-mediated antifungal immunity has been implicated as the major pathway for fungal defense in the oral cavity. The IL-17 pathway has been found to regulate the release of antimicrobial peptides (AMPs) downstream, including murine β-defensin 3 (mBD3). Murine β-defensin 3 is an antimicrobial peptide involved in the protection of the oral mucosa against pathogens. Murine BD3 can protect the oral mucosa through its direct antimicrobial activity, but it has also been found to have chemotactic properties as well.
    [Show full text]